Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Randomized phase II study of preoperative chemoradiotherapy (CRT) plus /-Panitumumab (P) followed by consolidation chemotherapy (C) in potentially operable locally advanced (stage Ma, N2+) non -small cell lung cancer (LANSCLC): Nrg oncology/RTOG 0839. Edelman, M. J., Hu, C., Le, Q., Donington, J., D'Souza, W. D., Dicker, A., Loo, B. W., Gore, E., Videtic, G. M., Evans, N. R., Leach, J., Diehn, M., Feigenberg, S. J., Chen, Y., Bradley, J. D. AMER SOC CLINICAL ONCOLOGY. 2016
View details for DOI 10.1200/JCO.2016.34.15_suppl.8510
View details for Web of Science ID 000404711505242